

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 8.39665737 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.74646156 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 7.36959638 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.30540487 |
| 5 | regulation of B cell differentiation (GO:0045577) | 5.90935678 |
| 6 | cellular response to zinc ion (GO:0071294) | 5.76443810 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.62560864 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.62560864 |
| 9 | cytidine metabolic process (GO:0046087) | 5.25684285 |
| 10 | cytidine catabolic process (GO:0006216) | 5.25684285 |
| 11 | cytidine deamination (GO:0009972) | 5.25684285 |
| 12 | positive regulation of B cell differentiation (GO:0045579) | 5.08563726 |
| 13 | B cell proliferation (GO:0042100) | 5.07046724 |
| 14 | positive thymic T cell selection (GO:0045059) | 5.03617136 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.93865459 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.70270992 |
| 17 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.68374642 |
| 18 | mature B cell differentiation (GO:0002335) | 4.65905171 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.56265353 |
| 20 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.54358060 |
| 21 | cellular response to interleukin-15 (GO:0071350) | 4.53671974 |
| 22 | response to interleukin-15 (GO:0070672) | 4.48765883 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 4.38670563 |
| 24 | regulation of B cell proliferation (GO:0030888) | 4.35322878 |
| 25 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.34735377 |
| 26 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.34333753 |
| 27 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.34333753 |
| 28 | negative regulation of B cell proliferation (GO:0030889) | 4.34296037 |
| 29 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.33788419 |
| 30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.30456060 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.25478583 |
| 32 | defense response to protozoan (GO:0042832) | 4.22804001 |
| 33 | detection of other organism (GO:0098543) | 4.18382467 |
| 34 | detection of bacterium (GO:0016045) | 4.18128264 |
| 35 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.17170797 |
| 36 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.15667402 |
| 37 | negative thymic T cell selection (GO:0045060) | 4.13393535 |
| 38 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.07197906 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 4.02850366 |
| 40 | regulation of B cell apoptotic process (GO:0002902) | 4.01926882 |
| 41 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.01154505 |
| 42 | thymic T cell selection (GO:0045061) | 3.92717678 |
| 43 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.92192024 |
| 44 | germinal center formation (GO:0002467) | 3.84399578 |
| 45 | B cell homeostasis (GO:0001782) | 3.83997067 |
| 46 | positive regulation of granulocyte differentiation (GO:0030854) | 3.83731946 |
| 47 | negative T cell selection (GO:0043383) | 3.82076842 |
| 48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.80381992 |
| 49 | NIK/NF-kappaB signaling (GO:0038061) | 3.75574432 |
| 50 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.75490160 |
| 51 | positive regulation of B cell proliferation (GO:0030890) | 3.72606520 |
| 52 | positive regulation of interferon-alpha production (GO:0032727) | 3.70777161 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 3.69086459 |
| 54 | B cell activation (GO:0042113) | 3.67376687 |
| 55 | activated T cell proliferation (GO:0050798) | 3.64542626 |
| 56 | negative regulation of B cell apoptotic process (GO:0002903) | 3.64475403 |
| 57 | lymphocyte homeostasis (GO:0002260) | 3.60042541 |
| 58 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.59366267 |
| 59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.59289518 |
| 60 | response to protozoan (GO:0001562) | 3.57955322 |
| 61 | T cell selection (GO:0045058) | 3.55283472 |
| 62 | regulation of interferon-alpha production (GO:0032647) | 3.55222890 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 3.54717026 |
| 64 | lymph node development (GO:0048535) | 3.54534421 |
| 65 | positive T cell selection (GO:0043368) | 3.54346604 |
| 66 | mature B cell differentiation involved in immune response (GO:0002313) | 3.52562438 |
| 67 | tolerance induction (GO:0002507) | 3.51292133 |
| 68 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.48581940 |
| 69 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.46947846 |
| 70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.46009286 |
| 71 | negative regulation of T cell mediated immunity (GO:0002710) | 3.44698548 |
| 72 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.43573072 |
| 73 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.43573072 |
| 74 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.42930901 |
| 75 | regulation of B cell activation (GO:0050864) | 3.41815675 |
| 76 | negative regulation of phagocytosis (GO:0050765) | 3.39124612 |
| 77 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.36170221 |
| 78 | respiratory burst (GO:0045730) | 3.35957825 |
| 79 | positive regulation of B cell activation (GO:0050871) | 3.35353014 |
| 80 | detection of external biotic stimulus (GO:0098581) | 3.34953713 |
| 81 | T cell migration (GO:0072678) | 3.33605270 |
| 82 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.33029623 |
| 83 | cellular extravasation (GO:0045123) | 3.31739026 |
| 84 | T cell homeostasis (GO:0043029) | 3.26271443 |
| 85 | positive regulation of interleukin-2 production (GO:0032743) | 3.25326183 |
| 86 | leukocyte aggregation (GO:0070486) | 3.24813940 |
| 87 | positive regulation of Rap GTPase activity (GO:0032854) | 3.22961955 |
| 88 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21670134 |
| 89 | lymphocyte proliferation (GO:0046651) | 3.21467794 |
| 90 | T cell costimulation (GO:0031295) | 3.20337229 |
| 91 | mononuclear cell proliferation (GO:0032943) | 3.19836845 |
| 92 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.19791622 |
| 93 | leukocyte homeostasis (GO:0001776) | 3.19499495 |
| 94 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.18705336 |
| 95 | positive regulation of immunoglobulin production (GO:0002639) | 3.18074564 |
| 96 | B cell mediated immunity (GO:0019724) | 3.17163508 |
| 97 | negative regulation of cell killing (GO:0031342) | 3.17026393 |
| 98 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.17026393 |
| 99 | lymphocyte costimulation (GO:0031294) | 3.13002382 |
| 100 | macrophage activation involved in immune response (GO:0002281) | 3.11546906 |
| 101 | positive regulation of type 2 immune response (GO:0002830) | 3.10803217 |
| 102 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.10656459 |
| 103 | negative regulation of adaptive immune response (GO:0002820) | 3.09552046 |
| 104 | positive regulation by symbiont of host defense response (GO:0052509) | 3.06186870 |
| 105 | modulation by symbiont of host defense response (GO:0052031) | 3.06186870 |
| 106 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.06186870 |
| 107 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.06186870 |
| 108 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.06186870 |
| 109 | modulation by symbiont of host immune response (GO:0052553) | 3.06186870 |
| 110 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.05010757 |
| 111 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.05010757 |
| 112 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.05010757 |
| 113 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.01612706 |
| 114 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.00372075 |
| 115 | myeloid cell activation involved in immune response (GO:0002275) | 2.99889557 |
| 116 | regulation of mast cell degranulation (GO:0043304) | 2.99421173 |
| 117 | regulation of tolerance induction (GO:0002643) | 2.98978029 |
| 118 | cellular response to type I interferon (GO:0071357) | 2.97719841 |
| 119 | type I interferon signaling pathway (GO:0060337) | 2.97719841 |
| 120 | response to type I interferon (GO:0034340) | 2.97516964 |
| 121 | interferon-gamma production (GO:0032609) | 2.97045257 |
| 122 | positive regulation of mast cell activation (GO:0033005) | 2.95927321 |
| 123 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.95875797 |
| 124 | regulation of mast cell activation (GO:0033003) | 2.95339282 |
| 125 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.95316456 |
| 126 | B cell differentiation (GO:0030183) | 2.95137766 |
| 127 | regulation of antigen processing and presentation (GO:0002577) | 2.93687060 |
| 128 | immune response-activating signal transduction (GO:0002757) | 2.92642721 |
| 129 | regulation of T cell tolerance induction (GO:0002664) | 2.92565157 |
| 130 | regulation of granulocyte differentiation (GO:0030852) | 2.91713082 |
| 131 | B cell activation involved in immune response (GO:0002312) | 2.91611100 |
| 132 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.90701572 |
| 133 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.89604314 |
| 134 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.88635040 |
| 135 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.88518346 |
| 136 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.88139473 |
| 137 | neutrophil activation (GO:0042119) | 2.87408077 |
| 138 | regulation of germinal center formation (GO:0002634) | 2.86324434 |
| 139 | mast cell activation (GO:0045576) | 2.86119898 |
| 140 | T cell receptor signaling pathway (GO:0050852) | 2.85762436 |
| 141 | leukocyte proliferation (GO:0070661) | 2.85599124 |
| 142 | microglial cell activation (GO:0001774) | 2.85372991 |
| 143 | histone H3-K36 demethylation (GO:0070544) | 2.84403861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.92259817 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.78297431 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.63107549 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 4.39426494 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.25728764 |
| 6 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.09790258 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.41277330 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.36222461 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31148651 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.14309501 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.12697915 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.91253733 |
| 13 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.75488752 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.75122414 |
| 15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.57552641 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.53149180 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.52655233 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.51185318 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47096979 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.37485116 |
| 21 | * MYB_26560356_Chip-Seq_TH1_Human | 2.36662134 |
| 22 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31440282 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28336369 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.26822439 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23424514 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.23323198 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22216291 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.21366732 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.18914668 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.10809287 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.07496726 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07364888 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97039146 |
| 34 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.96195576 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94733652 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88578093 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88295263 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87073618 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84298545 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83632419 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.81527283 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.78068411 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.74500848 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.71863374 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69788098 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68289110 |
| 47 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63936900 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60041015 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58874660 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56239656 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53666561 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49011556 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46838695 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46123522 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45679614 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.41211500 |
| 57 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.36322853 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34225328 |
| 59 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.31646510 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29993775 |
| 61 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.27407350 |
| 62 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.27137911 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26613389 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25336499 |
| 65 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.24673394 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24325906 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22860509 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22194500 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21701563 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19259415 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15243872 |
| 72 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14321009 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13895683 |
| 74 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13760280 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13747000 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12083472 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09824924 |
| 78 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08183973 |
| 79 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.08055061 |
| 80 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.07479101 |
| 81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03525101 |
| 82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99494654 |
| 83 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.99445619 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97902962 |
| 85 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96441916 |
| 86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96095662 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95858758 |
| 88 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94729290 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94569340 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90045483 |
| 91 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.89369736 |
| 92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88705083 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87412703 |
| 94 | P300_27268052_Chip-Seq_Bcells_Human | 0.84276958 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83745702 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83414828 |
| 97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83382746 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82581817 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81787334 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.81753272 |
| 101 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81308150 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81273986 |
| 103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80956717 |
| 104 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.79974816 |
| 105 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79333592 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78489818 |
| 107 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.78110355 |
| 108 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.77638731 |
| 109 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77320747 |
| 110 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77276191 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.76300048 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75882928 |
| 113 | GATA3_26560356_Chip-Seq_TH1_Human | 0.74132528 |
| 114 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.73536825 |
| 115 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73457927 |
| 116 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73246839 |
| 117 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.73188097 |
| 118 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72401436 |
| 119 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.71456498 |
| 120 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68104585 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66747362 |
| 122 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.65899958 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65825956 |
| 124 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.64465891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.91422097 |
| 2 | MP0001800_abnormal_humoral_immune | 4.81765806 |
| 3 | MP0005387_immune_system_phenotype | 4.77883802 |
| 4 | MP0001790_abnormal_immune_system | 4.77883802 |
| 5 | MP0000685_abnormal_immune_system | 4.01812163 |
| 6 | MP0002452_abnormal_antigen_presenting | 3.73762616 |
| 7 | MP0003303_peritoneal_inflammation | 3.44658032 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.43227808 |
| 9 | MP0005671_abnormal_response_to | 3.39147855 |
| 10 | MP0003724_increased_susceptibility_to | 3.28515593 |
| 11 | MP0002723_abnormal_immune_serum | 3.23476534 |
| 12 | MP0002420_abnormal_adaptive_immunity | 3.13041870 |
| 13 | MP0001819_abnormal_immune_cell | 3.03769255 |
| 14 | MP0002398_abnormal_bone_marrow | 2.86894059 |
| 15 | MP0000716_abnormal_immune_system | 2.65531834 |
| 16 | MP0000689_abnormal_spleen_morphology | 2.61413478 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.61055602 |
| 18 | MP0005025_abnormal_response_to | 2.34292068 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.26626680 |
| 20 | MP0009785_altered_susceptibility_to | 2.21427003 |
| 21 | MP0002419_abnormal_innate_immunity | 2.21134663 |
| 22 | MP0002429_abnormal_blood_cell | 2.18870205 |
| 23 | MP0002722_abnormal_immune_system | 2.16957631 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.15973445 |
| 25 | MP0003436_decreased_susceptibility_to | 2.08602820 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.03030959 |
| 27 | MP0001873_stomach_inflammation | 2.01200889 |
| 28 | MP0003300_gastrointestinal_ulcer | 2.00675576 |
| 29 | MP0002405_respiratory_system_inflammati | 2.00049332 |
| 30 | MP0003787_abnormal_imprinting | 1.96797860 |
| 31 | MP0004510_myositis | 1.95616264 |
| 32 | MP0001853_heart_inflammation | 1.92543989 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.80828850 |
| 34 | MP0004381_abnormal_hair_follicle | 1.74123154 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.68633841 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.64352579 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.61860713 |
| 38 | MP0002009_preneoplasia | 1.55274856 |
| 39 | MP0004947_skin_inflammation | 1.53013549 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.52432919 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.52208393 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.51466538 |
| 43 | MP0002933_joint_inflammation | 1.50125369 |
| 44 | MP0005310_abnormal_salivary_gland | 1.45457224 |
| 45 | MP0008057_abnormal_DNA_replication | 1.41324565 |
| 46 | MP0002006_tumorigenesis | 1.40279135 |
| 47 | MP0003866_abnormal_defecation | 1.39705433 |
| 48 | MP0004883_abnormal_blood_vessel | 1.37342232 |
| 49 | MP0001986_abnormal_taste_sensitivity | 1.36760848 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.28829911 |
| 51 | MP0006082_CNS_inflammation | 1.19450711 |
| 52 | MP0008469_abnormal_protein_level | 1.15197040 |
| 53 | MP0002132_abnormal_respiratory_system | 1.11438435 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.08228888 |
| 55 | MP0001851_eye_inflammation | 1.04759465 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.03868946 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.02718896 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.01551076 |
| 59 | MP0008877_abnormal_DNA_methylation | 0.99000897 |
| 60 | MP0003077_abnormal_cell_cycle | 0.97099497 |
| 61 | MP0002136_abnormal_kidney_physiology | 0.91932629 |
| 62 | MP0005451_abnormal_body_composition | 0.91043308 |
| 63 | MP0010094_abnormal_chromosome_stability | 0.89847612 |
| 64 | MP0003172_abnormal_lysosome_physiology | 0.85550011 |
| 65 | MP0003091_abnormal_cell_migration | 0.81874473 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 0.81219298 |
| 67 | MP0000569_abnormal_digit_pigmentation | 0.80193641 |
| 68 | MP0003045_fibrosis | 0.78364298 |
| 69 | MP0009278_abnormal_bone_marrow | 0.78053370 |
| 70 | MP0002928_abnormal_bile_duct | 0.77047136 |
| 71 | MP0000490_abnormal_crypts_of | 0.75858045 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 0.74547278 |
| 73 | MP0001545_abnormal_hematopoietic_system | 0.74547278 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.74222870 |
| 75 | MP0001533_abnormal_skeleton_physiology | 0.74084467 |
| 76 | MP0005058_abnormal_lysosome_morphology | 0.72475859 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.72325315 |
| 78 | MP0009764_decreased_sensitivity_to | 0.69869049 |
| 79 | MP0003693_abnormal_embryo_hatching | 0.69553697 |
| 80 | MP0004484_altered_response_of | 0.67036729 |
| 81 | MP0005164_abnormal_response_to | 0.64970836 |
| 82 | MP0002095_abnormal_skin_pigmentation | 0.64652159 |
| 83 | MP0008004_abnormal_stomach_pH | 0.61056217 |
| 84 | MP0003690_abnormal_glial_cell | 0.60466537 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.60233401 |
| 86 | MP0005166_decreased_susceptibility_to | 0.60215820 |
| 87 | MP0003566_abnormal_cell_adhesion | 0.60078370 |
| 88 | MP0001879_abnormal_lymphatic_vessel | 0.59953003 |
| 89 | MP0000249_abnormal_blood_vessel | 0.59822541 |
| 90 | MP0008874_decreased_physiological_sensi | 0.59716356 |
| 91 | MP0002909_abnormal_adrenal_gland | 0.59366472 |
| 92 | MP0005076_abnormal_cell_differentiation | 0.59073523 |
| 93 | MP0002998_abnormal_bone_remodeling | 0.56733837 |
| 94 | MP0004130_abnormal_muscle_cell | 0.56389281 |
| 95 | MP0005621_abnormal_cell_physiology | 0.55919347 |
| 96 | MP0001663_abnormal_digestive_system | 0.55438752 |
| 97 | MP0000350_abnormal_cell_proliferation | 0.55088171 |
| 98 | MP0000313_abnormal_cell_death | 0.54673191 |
| 99 | MP0003448_altered_tumor_morphology | 0.54225323 |
| 100 | MP0000858_altered_metastatic_potential | 0.54017420 |
| 101 | MP0005381_digestive/alimentary_phenotyp | 0.53518432 |
| 102 | MP0000372_irregular_coat_pigmentation | 0.52543865 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.52310009 |
| 104 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52072742 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.51703111 |
| 106 | MP0006054_spinal_hemorrhage | 0.51418121 |
| 107 | MP0003252_abnormal_bile_duct | 0.50880931 |
| 108 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.50236180 |
| 109 | MP0009763_increased_sensitivity_to | 0.49729108 |
| 110 | MP0005023_abnormal_wound_healing | 0.48111688 |
| 111 | MP0003111_abnormal_nucleus_morphology | 0.47836627 |
| 112 | MP0008058_abnormal_DNA_repair | 0.47830657 |
| 113 | MP0000609_abnormal_liver_physiology | 0.47608802 |
| 114 | MP0001348_abnormal_lacrimal_gland | 0.47271497 |
| 115 | MP0008260_abnormal_autophagy | 0.46524363 |
| 116 | MP0005075_abnormal_melanosome_morpholog | 0.46441144 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.46156742 |
| 118 | MP0003828_pulmonary_edema | 0.46018929 |
| 119 | MP0003453_abnormal_keratinocyte_physiol | 0.45642689 |
| 120 | MP0000371_diluted_coat_color | 0.44945589 |
| 121 | MP0010307_abnormal_tumor_latency | 0.44319592 |
| 122 | MP0004957_abnormal_blastocyst_morpholog | 0.43317792 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.42707125 |
| 124 | MP0002693_abnormal_pancreas_physiology | 0.42527668 |
| 125 | MP0002277_abnormal_respiratory_mucosa | 0.42084917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 8.91070240 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 7.98311077 |
| 3 | Recurrent bronchitis (HP:0002837) | 6.67569648 |
| 4 | Recurrent sinusitis (HP:0011108) | 6.17867812 |
| 5 | Colitis (HP:0002583) | 5.92727265 |
| 6 | Cellulitis (HP:0100658) | 5.71418953 |
| 7 | IgM deficiency (HP:0002850) | 5.54996111 |
| 8 | Lymphopenia (HP:0001888) | 5.13501120 |
| 9 | Inflammation of the large intestine (HP:0002037) | 5.10048490 |
| 10 | Emphysema (HP:0002097) | 5.00351958 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.95964004 |
| 12 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.93932896 |
| 13 | Gastrointestinal inflammation (HP:0004386) | 4.89634167 |
| 14 | Verrucae (HP:0200043) | 4.76792355 |
| 15 | Papilloma (HP:0012740) | 4.76792355 |
| 16 | Recurrent viral infections (HP:0004429) | 4.74061054 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 4.62170193 |
| 18 | IgA deficiency (HP:0002720) | 4.56713019 |
| 19 | Meningitis (HP:0001287) | 4.49826341 |
| 20 | Chronic sinusitis (HP:0011109) | 4.48842728 |
| 21 | Recurrent abscess formation (HP:0002722) | 4.34656484 |
| 22 | Vasculitis (HP:0002633) | 4.32941233 |
| 23 | Chronic otitis media (HP:0000389) | 4.27456066 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 4.08624396 |
| 25 | Recurrent lower respiratory tract infections (HP:0002783) | 4.00950059 |
| 26 | Recurrent pneumonia (HP:0006532) | 3.90106975 |
| 27 | Bronchitis (HP:0012387) | 3.87244909 |
| 28 | Restrictive lung disease (HP:0002091) | 3.85705414 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.77137148 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.77137148 |
| 31 | Osteomyelitis (HP:0002754) | 3.71299981 |
| 32 | Recurrent fungal infections (HP:0002841) | 3.67896048 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 3.62503572 |
| 34 | Optic neuritis (HP:0100653) | 3.62503572 |
| 35 | Recurrent otitis media (HP:0000403) | 3.54482802 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 3.46608521 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 3.43590045 |
| 38 | Eczematoid dermatitis (HP:0000976) | 3.41019267 |
| 39 | Chronic diarrhea (HP:0002028) | 3.39025026 |
| 40 | IgG deficiency (HP:0004315) | 3.38095918 |
| 41 | Orchitis (HP:0100796) | 3.36762965 |
| 42 | Recurrent skin infections (HP:0001581) | 3.33774345 |
| 43 | Abnormality of T cell physiology (HP:0011840) | 3.26785973 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 3.21318521 |
| 45 | Prolonged bleeding time (HP:0003010) | 3.14926606 |
| 46 | Abnormality of T cells (HP:0002843) | 3.07490155 |
| 47 | Abnormality of B cell number (HP:0010975) | 3.06856026 |
| 48 | B lymphocytopenia (HP:0010976) | 3.06856026 |
| 49 | Small epiphyses (HP:0010585) | 2.98898510 |
| 50 | Sepsis (HP:0100806) | 2.95284707 |
| 51 | Leukopenia (HP:0001882) | 2.95180977 |
| 52 | Abnormality of the fingertips (HP:0001211) | 2.93749452 |
| 53 | Lymphoma (HP:0002665) | 2.92567895 |
| 54 | Viral hepatitis (HP:0006562) | 2.90093164 |
| 55 | Thyroiditis (HP:0100646) | 2.83749573 |
| 56 | Thrombocytosis (HP:0001894) | 2.72165927 |
| 57 | Abnormality of T cell number (HP:0011839) | 2.63385694 |
| 58 | Leukocytosis (HP:0001974) | 2.62135904 |
| 59 | Hemoptysis (HP:0002105) | 2.60994326 |
| 60 | Keratoconjunctivitis sicca (HP:0001097) | 2.60048933 |
| 61 | Nasal polyposis (HP:0100582) | 2.57932419 |
| 62 | T lymphocytopenia (HP:0005403) | 2.57129575 |
| 63 | Interstitial pulmonary disease (HP:0006530) | 2.56191658 |
| 64 | Mitral stenosis (HP:0001718) | 2.55914510 |
| 65 | Abnormality of the prostate (HP:0008775) | 2.54115648 |
| 66 | Epistaxis (HP:0000421) | 2.53597526 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.53526315 |
| 68 | Obstructive lung disease (HP:0006536) | 2.53526315 |
| 69 | Keratoconjunctivitis (HP:0001096) | 2.51299243 |
| 70 | Gingival bleeding (HP:0000225) | 2.44781104 |
| 71 | Pustule (HP:0200039) | 2.44781099 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43174541 |
| 73 | Hypoplasia of the thymus (HP:0000778) | 2.42459170 |
| 74 | Encephalitis (HP:0002383) | 2.42189223 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.41313633 |
| 76 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.40618663 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.38760605 |
| 78 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.34418002 |
| 79 | Skin ulcer (HP:0200042) | 2.31124071 |
| 80 | Skin rash (HP:0000988) | 2.30281950 |
| 81 | Pulmonary embolism (HP:0002204) | 2.26015665 |
| 82 | Abnormality of eosinophils (HP:0001879) | 2.25296317 |
| 83 | Abnormality of the pleura (HP:0002103) | 2.23157839 |
| 84 | Arthralgia (HP:0002829) | 2.22634835 |
| 85 | Spontaneous hematomas (HP:0007420) | 2.18612497 |
| 86 | Increased IgE level (HP:0003212) | 2.16257456 |
| 87 | Hypochromic microcytic anemia (HP:0004840) | 2.15104419 |
| 88 | Abnormality of the nasal mucosa (HP:0000433) | 2.13429546 |
| 89 | Hypochromic anemia (HP:0001931) | 2.09635852 |
| 90 | Stomach cancer (HP:0012126) | 2.08398741 |
| 91 | Hematochezia (HP:0002573) | 2.08220848 |
| 92 | Neutropenia (HP:0001875) | 2.07308499 |
| 93 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.05047438 |
| 94 | Arterial thrombosis (HP:0004420) | 2.03236745 |
| 95 | Myositis (HP:0100614) | 2.00732712 |
| 96 | Fatigue (HP:0012378) | 1.99948168 |
| 97 | Vertebral arch anomaly (HP:0008438) | 1.98554281 |
| 98 | Abnormality of macrophages (HP:0004311) | 1.96700305 |
| 99 | Papilledema (HP:0001085) | 1.94630863 |
| 100 | Increased IgM level (HP:0003496) | 1.93004786 |
| 101 | Villous atrophy (HP:0011473) | 1.91690630 |
| 102 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.91690630 |
| 103 | Anorexia (HP:0002039) | 1.91372800 |
| 104 | Gangrene (HP:0100758) | 1.88227229 |
| 105 | Microcytic anemia (HP:0001935) | 1.86979124 |
| 106 | Xerostomia (HP:0000217) | 1.86310964 |
| 107 | Flattened epiphyses (HP:0003071) | 1.85787172 |
| 108 | Gingivitis (HP:0000230) | 1.85665273 |
| 109 | Stomatitis (HP:0010280) | 1.81304846 |
| 110 | Episodic fever (HP:0001954) | 1.81217405 |
| 111 | Hepatitis (HP:0012115) | 1.80924319 |
| 112 | Combined immunodeficiency (HP:0005387) | 1.78265495 |
| 113 | Acrocyanosis (HP:0001063) | 1.75003194 |
| 114 | Irregular vertebral endplates (HP:0003301) | 1.73466934 |
| 115 | Periodontitis (HP:0000704) | 1.72742306 |
| 116 | Chest pain (HP:0100749) | 1.70539233 |
| 117 | Eosinophilia (HP:0001880) | 1.67987311 |
| 118 | Basal cell carcinoma (HP:0002671) | 1.66956968 |
| 119 | Urticaria (HP:0001025) | 1.62725689 |
| 120 | Absent epiphyses (HP:0010577) | 1.58573815 |
| 121 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.58573815 |
| 122 | Myocardial infarction (HP:0001658) | 1.57969610 |
| 123 | Mucosal telangiectasiae (HP:0100579) | 1.57755288 |
| 124 | Granulocytopenia (HP:0001913) | 1.55467795 |
| 125 | Petechiae (HP:0000967) | 1.54343380 |
| 126 | Hypergammaglobulinemia (HP:0010702) | 1.53555037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 7.42279238 |
| 2 | CSF1R | 3.48842583 |
| 3 | BLK | 3.27888767 |
| 4 | GRK6 | 2.88930337 |
| 5 | ERN1 | 2.88204712 |
| 6 | SYK | 2.74464613 |
| 7 | BTK | 2.60816598 |
| 8 | MAP3K13 | 2.58957019 |
| 9 | RIPK4 | 2.42150657 |
| 10 | KIT | 2.32287527 |
| 11 | MAP3K14 | 2.30531048 |
| 12 | STK10 | 2.25140366 |
| 13 | LRRK2 | 2.23085387 |
| 14 | MAP3K10 | 2.22292455 |
| 15 | TYK2 | 2.15532694 |
| 16 | BMPR2 | 1.97012369 |
| 17 | JAK1 | 1.91611922 |
| 18 | PRPF4B | 1.90648235 |
| 19 | LYN | 1.73473991 |
| 20 | TBK1 | 1.69321402 |
| 21 | SIK2 | 1.62352730 |
| 22 | JAK3 | 1.52609856 |
| 23 | IRAK4 | 1.51734928 |
| 24 | TEC | 1.51203958 |
| 25 | HCK | 1.50217441 |
| 26 | ZAP70 | 1.49808918 |
| 27 | CSK | 1.48040871 |
| 28 | IKBKB | 1.47739646 |
| 29 | ITK | 1.46564227 |
| 30 | IRAK3 | 1.42775432 |
| 31 | TGFBR2 | 1.37325661 |
| 32 | GRK1 | 1.29547247 |
| 33 | MST4 | 1.27985840 |
| 34 | CDK12 | 1.23160373 |
| 35 | LCK | 1.20512321 |
| 36 | PRKCQ | 1.19635415 |
| 37 | IKBKE | 1.19519093 |
| 38 | CDK19 | 1.17643162 |
| 39 | PRKCH | 1.14325200 |
| 40 | FES | 1.14042345 |
| 41 | CLK1 | 1.13442042 |
| 42 | FRK | 1.12304115 |
| 43 | MARK3 | 1.12110921 |
| 44 | EIF2AK3 | 1.07902356 |
| 45 | MARK2 | 1.04601834 |
| 46 | SIK3 | 1.03685470 |
| 47 | EEF2K | 1.02814501 |
| 48 | RPS6KA4 | 1.01071548 |
| 49 | IRAK1 | 0.98804853 |
| 50 | FLT3 | 0.92277255 |
| 51 | IRAK2 | 0.90457909 |
| 52 | FGFR4 | 0.86135971 |
| 53 | MATK | 0.86121556 |
| 54 | PIM1 | 0.85075539 |
| 55 | MAP2K3 | 0.83154794 |
| 56 | FGFR3 | 0.80720159 |
| 57 | PIK3CG | 0.80247984 |
| 58 | BRD4 | 0.78746159 |
| 59 | CHUK | 0.78739481 |
| 60 | YES1 | 0.77632389 |
| 61 | ALK | 0.75305977 |
| 62 | TAOK1 | 0.75050022 |
| 63 | TNK2 | 0.66301854 |
| 64 | CAMKK2 | 0.66225470 |
| 65 | FGR | 0.62909335 |
| 66 | MAP3K1 | 0.61852873 |
| 67 | CDC42BPA | 0.60723657 |
| 68 | MAP3K9 | 0.59516125 |
| 69 | TRIB3 | 0.58814542 |
| 70 | STK11 | 0.57818369 |
| 71 | ACVR1B | 0.56535504 |
| 72 | PDK1 | 0.56316264 |
| 73 | SGK2 | 0.55918184 |
| 74 | MAPK7 | 0.55765603 |
| 75 | DYRK1B | 0.55742550 |
| 76 | NEK2 | 0.54938096 |
| 77 | ABL1 | 0.54596193 |
| 78 | MAP3K3 | 0.52939109 |
| 79 | TXK | 0.52272472 |
| 80 | CCNB1 | 0.51898539 |
| 81 | SIK1 | 0.51660608 |
| 82 | PTK2B | 0.51438004 |
| 83 | EPHB1 | 0.48978642 |
| 84 | HIPK2 | 0.48942644 |
| 85 | MAPK12 | 0.47592129 |
| 86 | PDPK1 | 0.46973572 |
| 87 | KDR | 0.46768144 |
| 88 | SGK3 | 0.46089760 |
| 89 | PKN2 | 0.46081544 |
| 90 | CSNK1A1L | 0.45914567 |
| 91 | CAMKK1 | 0.45196631 |
| 92 | CDK4 | 0.44976606 |
| 93 | PRKCI | 0.43967145 |
| 94 | FYN | 0.43614840 |
| 95 | INSR | 0.43246460 |
| 96 | TESK2 | 0.42319794 |
| 97 | KSR2 | 0.41045640 |
| 98 | MAP3K7 | 0.40595237 |
| 99 | MELK | 0.40070016 |
| 100 | PRKD2 | 0.39459723 |
| 101 | PRKCD | 0.37564627 |
| 102 | NLK | 0.36976934 |
| 103 | EGFR | 0.36611909 |
| 104 | MAP3K2 | 0.36571989 |
| 105 | JAK2 | 0.36570092 |
| 106 | STK4 | 0.36185649 |
| 107 | MAP2K2 | 0.34873856 |
| 108 | NTRK2 | 0.33911358 |
| 109 | CAMK1D | 0.33806968 |
| 110 | CDK6 | 0.33677514 |
| 111 | SCYL2 | 0.33459301 |
| 112 | MAP3K8 | 0.31810163 |
| 113 | MAP3K11 | 0.30771091 |
| 114 | CAMK1G | 0.29908524 |
| 115 | DYRK1A | 0.29499558 |
| 116 | CAMK4 | 0.29079394 |
| 117 | PASK | 0.27093849 |
| 118 | CSNK1G3 | 0.26629780 |
| 119 | CSNK1G1 | 0.26589106 |
| 120 | MAPKAPK2 | 0.25964051 |
| 121 | NEK9 | 0.25846811 |
| 122 | PRKD1 | 0.25660389 |
| 123 | MAPK11 | 0.24617434 |
| 124 | CDK9 | 0.23519790 |
| 125 | RIPK1 | 0.23302232 |
| 126 | PTK6 | 0.23146147 |
| 127 | PRKCZ | 0.22676846 |
| 128 | MAPK4 | 0.21631716 |
| 129 | TLK1 | 0.20777802 |
| 130 | EIF2AK1 | 0.19873287 |
| 131 | RAF1 | 0.19727086 |
| 132 | TAOK3 | 0.17425720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.19005532 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 5.76746262 |
| 3 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.12695208 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.98765809 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.97093059 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.52576544 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25791132 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.23380498 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.11382778 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.97177923 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.85944170 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 1.85879757 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.73641236 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63544373 |
| 15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62938646 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.62131928 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.52424426 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49902920 |
| 19 | Mismatch repair_Homo sapiens_hsa03430 | 1.48685172 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46909556 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45732193 |
| 22 | DNA replication_Homo sapiens_hsa03030 | 1.41133483 |
| 23 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.32150169 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.31837281 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29369825 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.28508044 |
| 27 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27470571 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.25387780 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19951889 |
| 30 | Ribosome_Homo sapiens_hsa03010 | 1.19096812 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18800694 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.18642926 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18018452 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16571743 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12342453 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.10993943 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10366132 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.07760318 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02493393 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.01198309 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99131471 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96614115 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.95333287 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94386322 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90416525 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90304306 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89977186 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.89596141 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 0.89403645 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 0.87490599 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87202261 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84961321 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84638027 |
| 54 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81939124 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81732074 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76333501 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76107604 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75218598 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74924007 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72519752 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71973264 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71822063 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70921090 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 0.67937583 |
| 65 | Spliceosome_Homo sapiens_hsa03040 | 0.67388772 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66319715 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.65412911 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.65132671 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64730111 |
| 70 | Asthma_Homo sapiens_hsa05310 | 0.63724285 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62323974 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61259067 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60615467 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60008691 |
| 75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.59919484 |
| 76 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56155491 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54712778 |
| 78 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.54331619 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52425493 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50514267 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48398688 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48121957 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47555075 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47532831 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46449949 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.45252730 |
| 87 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42587670 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41851414 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.40916408 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40902804 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.39923607 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39364863 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37574972 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.36139481 |
| 95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.36093823 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35784141 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35358184 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30873394 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29977278 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29853738 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29217328 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27434455 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27132665 |
| 104 | Olfactory transduction_Homo sapiens_hsa04740 | 0.27132021 |
| 105 | Long-term depression_Homo sapiens_hsa04730 | 0.26933142 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25936395 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.25788300 |
| 108 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.24841312 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24638349 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23394922 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23033663 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23006999 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22582521 |
| 114 | RNA degradation_Homo sapiens_hsa03018 | 0.22176466 |
| 115 | Morphine addiction_Homo sapiens_hsa05032 | 0.21334410 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20910459 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20584817 |
| 118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20513626 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.19568742 |
| 120 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.19496404 |
| 121 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.19276204 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19090613 |
| 123 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18520369 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.18476314 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18453879 |
| 126 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.17150189 |

